Maxalt and Cimzia drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Maxalt (rizatriptan benzoate) and Cimzia (certolizumab pegol). Common drug interactions include pain among females and anhedonia among males.

The phase IV clinical study analyzes what interactions people have when they take Maxalt and Cimzia. It is created by eHealthMe based on reports of 41 people who take the same drugs from the FDA, and is updated regularly.

What is Maxalt?

Maxalt has active ingredients of rizatriptan benzoate. It is often used in migraine. eHealthMe is studying from 12,754 Maxalt users. Check the latest studies of Maxalt.

What is Cimzia?

Cimzia has active ingredients of certolizumab pegol. It is often used in rheumatoid arthritis. eHealthMe is studying from 106,745 Cimzia users. Check the latest studies of Cimzia.

On Jul, 07, 2026

41 people who take Maxalt and Cimzia together, and have interactions are studied.

What are the common drug interactions of Maxalt and Cimzia, by gender? *:

female:

Pain
Cystitis (inflammation of the wall of the bladder)
Injection site pain
Injection site haemorrhage (bleeding from injection site)
Injection site vesicles (fluid- or air-filled cavity or sac at injection site)
Pneumonia
Anxiety
Depression
Pruritus (severe itching of the skin)
Urticaria (rash of round, red welts on the skin that itch intensely)

male:

Anhedonia (inability to experience pleasure from activities usually found enjoyable)
Anxiety
Blood pressure increased
Headache (pain in head)
Metastatic malignant melanoma (spreadable cancer tumour of melanine)
Agitation (state of anxiety or nervous excitement)
Arthritis enteropathic (form of chronic, inflammatory arthritis associated with the occurrence of an inflammatory bowel disease)
Insomnia (sleeplessness)
Sinus tachycardia (a heart rhythm with elevated rate of impulses originating from the sinoatrial node)
Substance-induced psychotic disorder

What are the common drug interactions of Maxalt and Cimzia, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

Agitation (state of anxiety or nervous excitement)
Arthritis enteropathic (form of chronic, inflammatory arthritis associated with the occurrence of an inflammatory bowel disease)
Insomnia (sleeplessness)
Sinus tachycardia (a heart rhythm with elevated rate of impulses originating from the sinoatrial node)
Substance-induced psychotic disorder

20-29:

Anhedonia (inability to experience pleasure from activities usually found enjoyable)
Anxiety
Deformity (disfigurement)
Gallbladder disorder
Injury
Pain
Pancreatitis (inflammation of pancreas)
Septic shock (shock due to blood infection)
Thrombosis (formation of a blood clot inside a blood vessel)

30-39:

Anxiety
Urticaria (rash of round, red welts on the skin that itch intensely)
Pain
Convulsion (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled shaking of the body)
Rectal haemorrhage (bleeding from anus)
Dehydration (dryness resulting from the removal of water)
Depression
Infection
Rash macular (small, flat red spots)
Deep vein thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis)

40-49:

Vision blurred
Visual impairment

50-59:

Pruritus (severe itching of the skin)
Anxiety
Arthralgia (joint pain)
Breast cancer
Chest wall mass
Cough
Dizziness
Dry throat
Erythema (redness of the skin)
Herpes simplex (herpes simplex is a common viral infection)

60+:

Asthenia (weakness)
Cough
Skin nodule (slightly elevated lesions on or in the skin)
Cystitis (inflammation of the wall of the bladder)
Pneumonia
Pyrexia (fever)
Wheezing (a high-pitched whistling sound made while you breath)
Blood glucose increased
Blood pressure increased
Headache (pain in head)

What are the existing conditions these people have? *

Crohn's Disease (a condition that causes inflammation of the gastrointestinal tract): 12 people, 29.27%
Stress And Anxiety: 3 people, 7.32%
Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 3 people, 7.32%
Headache (pain in head): 3 people, 7.32%
Ankylosing Spondylitis (type of arthritis affecting the spine): 3 people, 7.32%

* Approximation only. Some reports may have incomplete information.

Do you take Maxalt and Cimzia?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously